Now in its tenth year, the event has grown to include novel immunotherapy biomarkers, cell-free DNA, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, clinical NGS assays, commercialization, reimbursement, prenatal testing, circulating tumor cells, critical care, forensics, digital PCR, microfluidics, and microbiome diagnostics.
Yan Lin Lye, Cambridge Consultants, will be giving a presentation on out-sourced diagnostics device development on the first day of the event.
Out-sourced diagnostics device development: getting it right
Date: Tuesday 21st August
Speaker: Yan Lin Lye, VP Business Development Asia, Cambridge Consultants
A brief overview of the presentation
- How to know when you're ready to outsource
- Understanding the art of the possible
- Critical questions that challenge potential partners
- The top three considerations when selecting your partner
Yan Lin Lye works for Cambridge Consultants as VP of Business Development and manages their Asia medtech portfolio. She specializes in developing innovative early-stage technologies and companies. Her previous experiences include being involved in developing sequencing, molecular diagnostics, and point-of-care platforms for both developed and developing world applications. Her experiences have ranged across North America, Europe, and Asia.